Treatment of cryoglobulinemia associated peripheral neuropathy with rituximab.
We describe a man with hepatitis C virus related cryoglobulinemic vasculitis that was resistant to combination treatment of prednisolone, interferon-alpha, and ribavirin, and that went into remission after treatment with rituximab.
Cai
Fin Zheng Jun
FZ
Rheumatology Department, The Repatriation General Hospital, Daw Park, South Australia, Australia.
Ahern
Michael
M
Smith
Malcolm
M
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D003449:Cryoglobulinemia / Q000150:complications / Q000188:drug therapy*; D024882:Drug Resistance, Viral; D004359:Drug Therapy, Combination; D019698:Hepatitis C, Chronic / Q000150:complications; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010523:Peripheral Nervous System Diseases / Q000150:complications / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use; D012074:Remission Induction; D012254:Ribavirin / Q000627:therapeutic use; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D016898:Interferon-alpha; D012254:Ribavirin; D000069283:Rituximab; D011239:Prednisolone